The fastest-growing and largest of the 20 sized Pharmaceuticals markets in North America, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $18.5 Bn | $157.3 Bn | 23.9% | 355 |
| 2 | Cell Based Immunotherapy | $8.3 Bn | $60.6 Bn | 22% | 8,825 |
| 3 | Cannabidiol (CBD) | $11 Bn | $47.8 Bn | 15.8% | 150 |
| 4 | Cannabis | $17 Bn | $55 Bn | 12.5% | 389 |
| 5 | Atopic Dermatitis Drugs | $5.6 Bn | $16.2 Bn | 11.2% | 117 |
| 6 | Oncology/Cancer Drugs | $88.5 Bn | $180.7 Bn | 7.4% | 9,646 |
| 7 | Anti-Aging | $44.1 Bn | $87.6 Bn | 7.1% | 1,129 |
| 8 | Diabetes Management | $39 Bn | $70.5 Bn | 6.1% | 1,374 |
| 9 | Alzheimer Drugs | $2.5 Bn | $4.4 Bn | 5.8% | 472 |
| 10 | Contraceptives Drugs | $12.6 Bn | $22.1 Bn | 5.8% | 53 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $88.5 Bn | $180.7 Bn | 7.4% | 9,646 |
| 2 | Anti-Aging | $44.1 Bn | $87.6 Bn | 7.1% | 1,129 |
| 3 | Diabetes Management | $39 Bn | $70.5 Bn | 6.1% | 1,374 |
| 4 | Gastrointestinal Drugs | $27 Bn | $38.5 Bn | 3.6% | 3,062 |
| 5 | Asthma & COPD Drugs | $24.8 Bn | $33.3 Bn | 3% | 381 |
| 6 | Biosimilars | $18.5 Bn | $157.3 Bn | 23.9% | 355 |
| 7 | Cannabis | $17 Bn | $55 Bn | 12.5% | 389 |
| 8 | HIV Drugs | $15 Bn | $24 Bn | 4.8% | 526 |
| 9 | Contraceptives Drugs | $12.6 Bn | $22.1 Bn | 5.8% | 53 |
| 10 | Cancer Supportive Care Drugs | $12.4 Bn | $17.8 Bn | 3.7% | 1,873 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in US, Canada.
Biosimilars grows fastest, at 23.9% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (22%).
Oncology/Cancer Drugs is the largest, worth about $88.5 Bn in 2023 and $180.7 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.